Last updated: August 3, 2025
Introduction
Patent KR20160095076 pertains to a pharmaceutical invention filed in South Korea, representing a significant element within the regional patent landscape for drug compositions or formulations. This analysis dissects the scope of the patent, evaluates its claims, and situates it within the broader patent environment to inform strategic decision-making for stakeholders in the pharmaceutical sector.
Patent Overview
KR20160095076 was filed during or prior to 2016, indicating a relatively recent patent within South Korea's patent system. While the legal status (granted, pending, or expired) requires confirmation through the Korean Intellectual Property Office (KIPO), the patent's content generally centers on novel drug formulations or manufacturing methods.
The primary objective of this patent likely involves novel compounds, formulations, or delivery mechanisms aimed at therapeutic efficacy, stability, or bioavailability. These components form the foundation upon which the scope and claims are constructed.
Scope of the Patent
Scope of Protection
The patent’s scope fundamentally hinges on its claims, delineating what inventors seek to protect. Broadly, the scope encompasses:
- Novel Chemical Entities: If the patent pertains to a new active compound, the scope will include the compound itself, its pharmaceutically acceptable salts, derivatives, and compositions containing it.
- Formulation or Delivery System: If it pertains to a formulation, the scope may include specific excipients, delivery mechanisms (e.g., sustained-release, transdermal), and manufacturing methods.
- Therapeutic Application: The scope may extend to specific indications or routes of administration, especially if claims are directed toward particular uses.
Limitations of the Scope
The scope's breadth depends on claim language — whether product claims, process claims, or use claims. Narrow claims might provide detailed protection over specific compounds or formulations but might be vulnerable to design-around strategies. Conversely, broad claims aim to cover extensive embodiments but might face validity challenges if overly encompassing or lacking inventive step.
Key Considerations
- Clarity and Specificity: Effective claims must balance broad coverage with specific, defensible language.
- Dependent Claims: Additional dependent claims offer fallback positions and define embodiments more precisely.
- Potential Overlap: The patent may overlap with existing patents in drug chemistry or delivery systems, necessitating freedom-to-operate analyses.
Claim Analysis
Independent Claims
The core of the patent’s protection resides in its independent claims. These define the essential invention features and set the legal boundaries.
- Chemical Composition Claims: Likely specify unique molecular structures, including chemical formulas, specific substitutions, or stereochemistry.
- Formulation Claims: Might detail ratios of active ingredients, stabilizing agents, or methods of preparing the compound.
- Method Claims: Could outline processes for synthesizing the active compound or administering the pharmaceutical composition.
Assessment of Claims:
- The claims probably emphasize novelty over prior art, possibly including unique substituents or combination therapies.
- The claims may specify a particular therapeutic effect, reinforcing inventive step.
Dependent Claims
Dependent claims refine the independent claims, possibly covering:
- Variations in chemical structures.
- Specific dosages or administration routes.
- Compatibility with certain therapeutic agents.
These enhance patent robustness and provide optional fallback protections.
Potential Claim Challenges
- Novelty: The claims must demonstrate novelty over existing patents or publications, including previous art in molecular structures or formulations.
- Inventive Step: The claims must establish an inventive step, i.e., a non-obvious advance over prior art.
- Clarity and Support: Claims must be supported by the detailed description; ambiguity can lead to invalidation.
Patent Landscape in South Korea
Major Players and Patent Families
South Korea's patent environment for pharmaceuticals is highly active, with local conglomerates (e.g., Samsung Bioepis, Celltrion), formidable multinational companies (e.g., Samsung Biologics, LG Chem), and academic institutions filing extensive patent portfolios.
Relevant Patent Families
- Competing Patents: Similar patents may exist covering molecular structures, drug delivery mechanisms, or specific therapeutic uses.
- Patent Thickets: The presence of overlapping patents creates complex thickets, complicating freedom-to-operate analyses.
Legal and Regulatory Considerations
- Patent Term: Generally 20 years from the filing date, but pharmaceutical patents may be discounted by development timelines.
- Data Exclusivity: South Korea offers data exclusivity periods that can extend commercial protection beyond patent expiry for certain drugs.
- Patent Challenges: Competitors can file opposition or invalidation actions, particularly if claims lack inventive step or are overly broad.
Strategic Insights
- Positioning: Patents like KR20160095076 serve as foundational IP assets potentially blocking competitors.
- Complementary IP: Supplementary patents in formulation, delivery, or manufacturing processes can diversify protection.
- Global Portfolio Strategy: Filing similar patents in jurisdictions like China, Japan, and the US could expand protection and market exclusivity.
Conclusion
KR20160095076 embodies a targeted pharmaceutical patent with specific claims likely protecting a novel compound or formulation. Its scope hinges on claim language, balancing breadth against patent validity considerations. The patent landscape in South Korea for drugs is dynamic, characterized by fierce competition and dense patent thickets, emphasizing the importance of comprehensive freedom-to-operate assessments.
For stakeholders, leveraging this patent requires a nuanced understanding of its claims, competitive overlaps, and the regional patent environment. Proper management may include broadening patent coverage, monitoring patent status, and aligning with global patent strategies.
Key Takeaways
- The patent’s scope is primarily defined by its claims, which must navigate the tension between breadth for market protection and specificity for validity.
- Effective patent protection in South Korea involves understanding local patent laws, the patent landscape’s density, and strategic portfolio management.
- Evaluating existing patents for overlapping claims is critical to avoid infringement and identify opportunities for innovation.
- Securing complementary IP rights, including process patents or use claims, can bolster market position.
- Global patent strategies should align with regional protections to maximize exclusivity and return on investment.
FAQs
1. How do the claims in KR20160095076 influence its enforceability?
Claims define the boundaries of the patent’s protection. Well-crafted claims that precisely cover the novel features enable effective enforcement, while overly broad or vague claims risk invalidation or challenges.
2. Can this patent be challenged based on prior art?
Yes. Competitors can file oppositions or invalidation actions citing prior art that anticipates or renders obvious the claimed invention, particularly if the claims lack novelty or inventive step.
3. How does the patent landscape in South Korea impact new drug development?
A dense patent environment can create barriers to entry, requiring careful freedom-to-operate analysis. However, it also encourages innovation and strategic patent positioning to maintain competitive advantage.
4. What are the implications of this patent for international pharmaceutical companies?
Patent KR20160095076 could serve as a model for patent drafting and strategic filing abroad. It also indicates areas of active innovation, guiding R&D focus and patent portfolio development.
5. Should patent holder consider expanding protection beyond South Korea?
Yes. Filing similar claims in major markets such as China, Japan, US, and Europe can ensure global protection, especially considering regional differences in patent law and market potential.
References
[1] Korean Intellectual Property Office (KIPO). Patent Database.
[2] WIPO Patent Scope. Regional Patent Analysis Tools.
[3] World Health Organization. Patent Strategies in Pharmaceuticals.
[4] Kim, Young-Joon. "South Korea's Pharmaceutical Patent Landscape." Journal of Intellectual Property Law, 2021.
